Acquisitions, Sale of Hospira Infusion Systems Net Assets, Collaborative Arrangement, Equity-Method Investments and Cost-Method Investment - Sale of Hospira Infusion Systems Net Assets to ICU Medical, Inc. (EH) (Details) - USD ($) shares in Millions, $ in Millions			3 Months Ended
		Feb. 03, 2017	Apr. 02, 2017	Apr. 03, 2016	Jan. 05, 2017	Oct. 06, 2016
Business Acquisition [Line Items]
Loss on sale of HIS net assets	[1],[2]		$ 37	$ 0
HIS [Member] | Disposed of by Sale [Member] | ICU Medical [Member]
Business Acquisition [Line Items]
Consideration transferred					$ 900	$ 1,000
Number of shares received in disposition		3.2
Value of shares received from disposition		$ 428
Promissory note		75
Cash received from disposition		200
Contingent consideration		$ 225
Ownership percentage			16.00%
Minimum share transfer restriction term		18 months
Term of promissory note		3 years
Loss on sale of HIS net assets			$ 37
Administrative service period		24 months
Maximum manufacturing service period		5 years
London Interbank Offered Rate (LIBOR) [Member] | HIS [Member] | Disposed of by Sale [Member] | ICU Medical [Member]
Business Acquisition [Line Items]
Interest rate of promissory note in year one		2.25%
Interest rate of promissory note in year two		2.50%
Interest rate of promissory note in year three		2.50%

[1] Amounts may not add due to rounding.

[2] In the first quarter of 2017, represents an incremental charge to amounts previously recorded to write down the HIS net assets to fair value less costs to sell related to the sale of HIS net assets to ICU Medical.